Fredun Pharmaceuticals (FREDUN) Share Price Falls 8.67%: What Drove Today’s Move
- September 16, 2026
- Posted by: Harsh Piplani
- Category: News
Fredun Pharmaceuticals Share Price came under pressure today, with the stock closing at Rs 1,210.20 after a decline of 8.67% from the previous close of Rs 1,325.05. The company’s market capitalisation stood at Rs 2,337.74 Cr, placing it in the Small Cap category. Today’s move is relevant because the supplied data confirms a clear same-day share price fall, but it does not establish a company-specific catalyst. That makes Fredun Pharmaceuticals Share Price Today a data-led stock news event rather than a story built around an unverified trigger. For readers tracking Fredun Pharmaceuticals Stock News, the useful starting point is the exact price action, the valuation metrics and the sector context that follow in this Univest analysis.
The stock opened at Rs 1,320, touched a high of Rs 1,359.85 and a low of Rs 1,193.35 during the session. Turnover stood at Rs 1.63 Cr. Those figures show the day’s range and traded value, while the verified numbers also show a gap between the current price and the earlier close. In this Fredun Pharmaceuticals Share Price review, Univest focuses only on what the data supports: what happened, where the stock sits on valuation, and how it compares with pharmaceuticals peers.
Fredun Pharmaceuticals (FREDUN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,210.2 |
| Previous Close | Rs 1,325.05 |
| Today's Move | -Rs 114.85 (-8.67%) |
| Open | Rs 1,320 |
| High | Rs 1,359.85 |
| Low | Rs 1,193.35 |
| Turnover | Rs 1.63 crore |
| Market Capitalisation | Rs 2,337.74 crore |
| Market Cap Category | Small Cap |
Fredun Pharmaceuticals Share Price Today declined by Rs 114.85, or 8.67%, from the previous close of Rs 1,325.05 to Rs 1,210.20. The session opened at Rs 1,320, moved as high as Rs 1,359.85 and fell to a low of Rs 1,193.35 before settling near the lower end of the day’s range. Turnover was Rs 1.63 Cr, which is the exact traded-value figure supplied for the session and should be read as a factual market metric, not as an explanation for the move. With market capitalisation at Rs 2,337.74 Cr, Fredun Pharmaceuticals fits the Small Cap category and remains a comparatively smaller company in market-value terms.
For readers searching Fredun Pharmaceuticals Share Price Fall or Fredun Pharmaceuticals Stock Falling Today, the verified takeaway is simple: the day recorded a sharp decline from the previous close, with price action spanning Rs 1,193.35 to Rs 1,359.85. The data confirms the fall, confirms the close, and confirms the turnover; it does not establish why the stock moved. That distinction matters in any disciplined stock analysis, and it is exactly how Univest frames Fredun Pharmaceuticals Share Price Today for investors who want facts before interpretation.
Fredun Pharmaceuticals (FREDUN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,337.74 crore |
| P/E Ratio | 50.01x |
| P/B Ratio | 7.47x |
| ROE | 16.09% |
| ROCE | 21.34% |
| EPS | Rs 26.5 |
| Book Value Per Share | Rs 177.38 |
| Dividend Yield | 0.02% |
Profitability metrics also add context. ROE is 16.09% and ROCE is 21.34%, both of which indicate the business is generating returns on equity and capital employed at levels that can be compared with sector benchmarks. Because Fredun Pharmaceuticals Financial Results were not otherwise supplied, the cleanest verified framework is to look at earnings quality through EPS, book value and return ratios. In Univest coverage, Fredun Pharmaceuticals Fundamental Analysis is therefore centred on exact numbers: market cap, P/E, P/B, ROE, ROCE, EPS, book value and dividend yield. Those figures help explain why the stock remains noteworthy even on a day when Fredun Pharmaceuticals Share Price declined.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 50.01x |
| Benchmark Median P/E | 31.74x |
| Benchmark Average P/E | 47.98x |
| Benchmark P/E Range | 3.29x to 683.37x |
| Company P/B Ratio | 7.47x |
| Benchmark Median P/B | 3.02x |
| Benchmark Average P/B | 4.44x |
| Company ROE | 16.09% |
| Benchmark Median ROE | 11.78% |
| Benchmark Average ROE | 11.19% |
| Company ROCE | 21.34% |
| Benchmark Median ROCE | 13.65% |
| Benchmark Average ROCE | 13.65% |
| Company Market Capitalisation | Rs 2,337.74 crore |
| Benchmark Median Market Cap | Rs 750.5 crore |
| Benchmark Average Market Cap | Rs 14,144.11 crore |
Fredun Pharmaceuticals operates in Healthcare, within the Pharmaceuticals & Drugs industry, and the supplied sector benchmark covers 200 companies in the same industry. Against that benchmark, Fredun Pharmaceuticals Share Price is valued at a P/E of 50.01 versus a median of 31.74 and an average of 47.98. That places the stock above the median and slightly above the average for the peer set. Its P/B of 7.47 is also above the benchmark median of 3.02 and average of 4.44. On return measures, ROE of 16.09% is above the benchmark median of 11.78% and average of 11.19%, while ROCE of 21.34% is above the median and average of 13.65%.
The market-cap benchmark is also useful. The sector median market capitalisation is Rs 750.5 Cr and the average is Rs 14,144.11 Cr, while Fredun Pharmaceuticals Market Cap stands at Rs 2,337.74 Cr. That puts the company above the median but well below the average, which reflects the wide size dispersion in the industry. In this sector analysis, Univest notes that Fredun Pharmaceuticals Share Price sits in a healthcare segment where valuation multiples vary sharply across listed companies. The exact benchmark scope and company count matter because they show the comparison set is broad and the observed ratios can be read against a large sample rather than a narrow sample.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,957.5 | 36.4 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,47,576 | 83.41 | 13.81 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,233.01 | 84.58 | 20.55 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,670.55 | 24.29 | 4.07 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,10,272.68 | 32.62 | 3.13 | 11.83 | 16 |
Fredun Pharmaceuticals Share Price can also be read against listed pharmaceutical peers supplied in the data set. Compared with Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla, Fredun Pharmaceuticals has a much smaller market cap at Rs 2,337.74 Cr. On valuation, its P/E of 50.01 is above Sun Pharma’s 36.4 and Cipla’s 32.62, but below Divi’s Laboratories at 83.41, Torrent Pharmaceuticals at 84.58 and Laurus Labs at 95.03 in the broader peer set.
On profitability, Fredun Pharmaceuticals’ ROE of 16.09% is higher than Sun Pharma, Cipla, Dr. Reddy’s and Aurobindo Pharma, while its ROCE of 21.34% is above Sun Pharma, Cipla, Dr. Reddy’s and Aurobindo Pharma and close to Divi’s Laboratories and Zydus Lifesciences. That combination of a relatively higher valuation than some large peers and decent return ratios is the key comparison point for Fredun Pharmaceuticals Stock News readers. Univest’s peer comparison view therefore shows a stock that is smaller in size than major pharma names, yet not weak on the return metrics that investors often track in a fundamental review.
Why Investors Are Watching Fredun Pharmaceuticals
- Fredun Pharmaceuticals Share Price fell 8.67% today to Rs 1,210.20.
- The previous close was Rs 1,325.05, while the day opened at Rs 1,320.
- The session high was Rs 1,359.85 and the session low was Rs 1,193.35.
- Market capitalisation stood at Rs 2,337.74 Cr, with the company in the Small Cap category.
- P/E was 50.01, P/B was 7.47, ROE was 16.09% and ROCE was 21.34%.
About Fredun Pharmaceuticals
Fredun Pharmaceuticals operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The verified data supplied for this article identifies the company by name, symbol and industry classification, which is enough to place Fredun Pharmaceuticals Share Price within a listed pharmaceutical context. Univest uses this factual base to track Fredun Pharmaceuticals Stock News, Fredun Pharmaceuticals Company News and Fredun Pharmaceuticals Share News without adding unsupported business details. For stock-market readers, the company’s profile is best understood through its sector membership, market capitalisation and valuation ratios.
Track Fredun Pharmaceuticals Share Price on Univest
Use Fredun Pharmaceuticals (FREDUN) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Fredun Pharmaceuticals Share Price on Univest for live updates, share price history, market cap, key valuation ratios, shareholding pattern, 52-week levels and broader market insights. Univest presents Fredun Pharmaceuticals Share Price Today in a structured format so users can follow the same stock news context, price action and company fundamentals in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Fredun Pharmaceuticals Share Price fall today?
Ans. The verified data shows Fredun Pharmaceuticals Share Price fell 8.67% today, but it does not establish a company-specific catalyst. The move is confirmed by the current price of Rs 1,210.20 versus the previous close of Rs 1,325.05.
What is Fredun Pharmaceuticals Share Price today?
Ans. Fredun Pharmaceuticals Share Price today is Rs 1,210.20. The stock declined Rs 114.85, or 8.67%, from the previous close, and the session ranged between Rs 1,193.35 and Rs 1,359.85. The previous close was Rs 1,325.05.
What is the market capitalisation of Fredun Pharmaceuticals?
Ans. Fredun Pharmaceuticals has a market capitalisation of Rs 2,337.74 Cr. The company is classified as Small Cap in the supplied data, which is factual company-size context rather than a view on quality.
How is Fredun Pharmaceuticals valued on earnings and book value?
Ans. Fredun Pharmaceuticals Share Price is supported by a P/E of 50.01 and a P/B of 7.47. EPS is Rs 26.5 and book value is Rs 177.38 per share, giving investors a clear valuation snapshot.
What do ROE and ROCE show for Fredun Pharmaceuticals?
Ans. Fredun Pharmaceuticals reports ROE of 16.09% and ROCE of 21.34%. These are return metrics, showing how the company’s earnings and capital employed compare with its sector benchmark. ROE stands at 16.09%.
How does Fredun Pharmaceuticals compare with healthcare peers?
Ans. Fredun Pharmaceuticals Share Price valuation sits above several large healthcare peers on P/E, while its ROE and ROCE compare favourably with some names in the supplied peer set. Its market cap is far smaller than major pharma companies.
Where does Fredun Pharmaceuticals operate?
Ans. Fredun Pharmaceuticals operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification places Fredun Pharmaceuticals Share Price within a broad listed pharmaceutical universe used for the sector comparison in this article.
